SPONSOR
Monash University
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3
Conditions studied: MyelomaNon Hodgkin's LymphomaLeukemiaSyphilisCardiovascular DiseasesType 2 Diabetes Mellitus (T2DM)Neurodegenerative DiseasesDementia
Monash University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Myeloma, Non Hodgkin's Lymphoma, Leukemia, Syphilis.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Monash University
How many clinical trials has Monash University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Monash University, of which 4 are actively recruiting participants. These trials cover conditions including Myeloma, Non Hodgkin's Lymphoma, Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Monash University research focus on?
Monash University clinical trials span Myeloma, Non Hodgkin's Lymphoma, Leukemia, Syphilis, Cardiovascular Diseases, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Monash University clinical trial?
To participate in a Monash University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Monash University trials with current recruitment status updated daily.
Clinical Trials by Monash University
NCT07202078 Phase 2, Phase 3
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Myeloma
NCT07300254
Recruiting
Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission
Syphilis
NCT07091162
Recruiting
EValuation Of poLygenic Scores and CT imAging In Risk Factor Modification in Patients With diabEtes
Cardiovascular Diseases
NCT06339190
Recruiting
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Neurodegenerative Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology